Table 1 Patients’ general characteristics
| Â | Characteristics at study initiation | ||
|---|---|---|---|
Number of patients (men/women) | 48 (15/33) | ||
Age (years) | 64.2 ± 7.3 | ||
HD duration (years) | 7.5 ± 7.3 | ||
Dry weight (kg) | 61.3 ± 15.7 | ||
Disease | |||
 Diabetes mellitus | 19 | ||
 Chronic glomerulonephritis | 12 | ||
 Nephrosclerosis | 3 | ||
 ADPKD | 6 | ||
 Others | 8 | ||
Comorbidities | |||
 Cardiovascular disease | 0/48 | ||
 Cerebrovascular disease | 4/48 | ||
Medication, n (%) | |||
 Antihypertensive medicines | 40 (83.3) | ||
 Renin-angiotensin system blocker | 31 (64.6) | ||
 Calcium channel blocker | 33 (68.8) | ||
 Beta blocker | 12 (25.0) | ||
 Alpha blocker | 8 (16.7) | ||
 Vitamin D analogue | 39 (79.6) | ||
 Phosphate binder | 41 (85.4) | ||
 Erythropoiesis-stimulating agent | 46 (95.8) | ||
Laboratory findings | |||
 Hb (g/dL) | 10.9 ± 0.8 | ||
 BUN (mg/dL) | 67.4 ± 15.5 | ||
 Serum creatinine (mg/dL) | 11.3 ± 2.3 | ||
 Na (mEq/L) | 138.7 ± 1.7 | ||
 K (mEq/L) | 5.0 ± 0.7 | ||
 Cl (mEq/L) | 104.1 ± 2.7 | ||
 Ca (mg/dL) | 8.7 ± 0.6 | ||
 P (mg/dL) | 5.4 ± 1.3 | ||
 Total protein (g/dL) | 6.4 ± 0.4 | ||
 Serum albumin (g/dL) | 3.7 ± 0.3 | ||
| Â | Standard HD | HD with BV-UFC | p-value |
n (total number of HD sessions) | 384 | 384 | Â |
Ultrafiltration (L/session) | 2.80 ± 0.84 | 2.79 ± 0.80 | 0.780 |
Systolic blood pressure (mmHg) | 151 ± 19 | 151 ± 19 | 0.933 |
Diastolic blood pressure (mmHg) | 80 ± 11 | 80 ± 12 | 0.158 |
Heart rate (beats/min) | 69.3 ± 9.3 | 69.8 ± 10.1 | 0.093 |
Kt/V urea | 1.45 ± 0.25 | 1.48 ± 0.24 | 0.720 |